Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 2608349, 12 pages
https://doi.org/10.1155/2017/2608349
Research Article

Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients

1Department of Trauma, Hand and Reconstructive Surgery, Goethe University, Frankfurt, Germany
2Department of General and Visceral Surgery, Goethe University, Frankfurt, Germany

Correspondence should be addressed to Borna Relja; moc.ajleranrob@ofni

Received 30 August 2016; Revised 8 November 2016; Accepted 27 November 2016; Published 1 February 2017

Academic Editor: Fumio Tsuji

Copyright © 2017 David Heftrig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Regel, P. Lobenhoffer, M. Grotz, H. C. Pape, U. Lehmann, and H. Tscherne, “Treatment results of patients with multiple trauma: an analysis of 3406 cases treated between 1972 and 1991 at a German Level I Trauma Center,” Journal of Trauma, vol. 38, no. 1, pp. 70–78, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Pfeifer, I. S. Tarkin, B. Rocos, and H.-C. Pape, “Patterns of mortality and causes of death in polytrauma patients—has anything changed?” Injury, vol. 40, no. 9, pp. 907–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Osborn, J. K. Tracy, J. R. Dunne, M. Pasquale, and L. M. Napolitano, “Epidemiology of sepsis in patients with traumatic injury,” Critical Care Medicine, vol. 32, no. 11, pp. 2234–2240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-Y. Seong and P. Matzinger, “Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses,” Nature Reviews Immunology, vol. 4, no. 6, pp. 469–478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine,” Chest, vol. 101, pp. 1644–1655, 1992. View at Google Scholar
  6. K. R. Kasten, H. S. Goetzman, M. R. Reid et al., “Divergent adaptive and innate immunological responses are observed in humans following blunt trauma,” BMC Immunology, vol. 11, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. C. Bone, “Sir Isaac Newton, sepsis, SIRS, and CARS,” Critical Care Medicine, vol. 24, no. 7, pp. 1125–1128, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. L. F. Gentile, A. G. Cuenca, P. A. Efron et al., “Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care,” Journal of Trauma and Acute Care Surgery, vol. 72, no. 6, pp. 1491–1501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Keel, N. Schregenberger, U. Steckholzer et al., “Endotoxin tolerance after severe injury and its regulatory mechanisms,” Journal of Trauma, vol. 41, no. 3, pp. 430–437, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Wutzler, M. Maier, M. Lehnert et al., “Suppression and recovery of LPS-stimulated monocyte activity after trauma is correlated with increasing injury severity: a prospective clinical study,” Journal of Trauma, vol. 66, no. 5, pp. 1273–1280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Relja, J. P. Horstmann, K. Kontradowitz et al., “Nlrp1 inflammasome is downregulated in trauma patients,” Journal of Molecular Medicine, vol. 93, no. 12, pp. 1391–1400, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Spolarics, M. Siddiqi, J. H. Siegel et al., “Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients,” Critical Care Medicine, vol. 31, no. 6, pp. 1722–1729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. S. Walsh, P. Thavichaigarn, K. Pattanapanyasat et al., “Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury,” Journal of Surgical Research, vol. 129, no. 2, pp. 221–230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Schinkel, R. Sendtner, S. Zimmer, and E. Faist, “Functional analysis of monocyte subsets in surgical sepsis,” Journal of Trauma, vol. 44, no. 5, pp. 743–749, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Hershman, W. G. Cheadle, S. R. Wellhausen, P. F. Davidson, and H. C. Polk Jr., “Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient,” British Journal of Surgery, vol. 77, no. 2, pp. 204–207, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Livingston, S. H. Appel, S. R. Wellhausen, G. Sonnenfeld, and H. C. Polk, “Depressed interferon gamma production and monocyte HLA-DR expression after severe injury,” Archives of Surgery, vol. 123, no. 11, pp. 1309–1312, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Cheron, B. Floccard, B. Allaouchiche et al., “Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma,” Critical Care, vol. 14, no. 6, article R208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Keel and O. Trentz, “Pathophysiology of polytrauma,” Injury, vol. 36, no. 6, pp. 691–709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Kohl, “The role of complement in danger sensing and transmission,” Immunologic Research, vol. 34, no. 2, pp. 157–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Takeda and S. Akira, “Toll-like receptors,” Current Protocols in Immunology, vol. 109, article 14, 2015. View at Google Scholar
  22. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Lien, T. J. Sellati, A. Yoshimura et al., “Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products,” Journal of Biological Chemistry, vol. 274, no. 47, pp. 33419–33425, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, “Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2,” Journal of Biological Chemistry, vol. 274, no. 25, pp. 17406–17409, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper, “Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock,” Clinical Microbiology Reviews, vol. 16, no. 3, pp. 379–414, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. D. Wright, R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison, “CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein,” Science, vol. 249, no. 4975, pp. 1431–1433, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Tian, A. M. Avalos, S.-Y. Mao et al., “Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE,” Nature Immunology, vol. 8, no. 5, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Eaton-Bassiri, S. B. Dillon, M. Cunningham et al., “Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells,” Infection and Immunity, vol. 72, no. 12, pp. 7202–7211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Ewaschuk, J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen, “Surface expression of toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA,” Infection and Immunity, vol. 75, no. 5, pp. 2572–2579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. K. U. Saikh, T. L. Kissner, A. Sultana, G. Ruthel, and R. G. Ulrich, “Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells,” Journal of Immunology, vol. 173, no. 12, pp. 7426–7434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Juarez, C. Nuñez, E. Sada, J. J. Ellner, S. K. Schwander, and M. Torres, “Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes,” Respiratory Research, vol. 11, article no. 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Adib-Conquy, P. Moine, K. Asehnoune et al., “Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 2, pp. 158–164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Pérez-Bárcena, V. Regueiro, C. Crespí et al., “Expression of toll-like receptors 2 and 4 is upregulated during hospital admission in traumatic patients: lack of correlation with blunted innate immune responses,” Annals of Surgery, vol. 251, no. 3, pp. 521–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Lendemans, E. Kreuzfelder, M. Rani et al., “Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system,” Journal of Trauma, vol. 63, no. 4, pp. 740–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Laudanski, A. De, S. Brouxhon, S. Kyrkanides, and C. Miller-Graziano, “Abnormal PGE2 regulation of monocyte TNF-α levels in trauma patients parallels development of a more macrophage-like phenotype,” Shock, vol. 22, no. 3, pp. 204–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies,” Journal of Clinical Epidemiology, vol. 61, no. 4, pp. 344–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. “Rating the severity of tissue damage. I. The abbreviated scale,” The Journal of the American Medical Association, vol. 215, no. 2, pp. 277–280, 1971. View at Publisher · View at Google Scholar
  40. AAAM, Abbreviated Injury Scale 2005 update 2008, Association for the Advancement of Automotive Medicine, Barrington, Ill, USA, 2005.
  41. M. Voth, S. Holzberger, B. Auner, D. Henrich, I. Marzi, and B. Relja, “I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course,” Clinical Chemistry and Laboratory Medicine, vol. 53, no. 5, pp. 771–780, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Relja, T. Lustenberger, B. Puttkammer et al., “Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications,” Immunobiology, vol. 218, no. 4, pp. 470–476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. E. Greisman, E. J. Young, and F. A. Carozza Jr., “Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance,” Journal of Immunology, vol. 103, no. 6, pp. 1223–1236, 1969. View at Google Scholar · View at Scopus
  44. W. Ertel, J.-P. Kremer, J. Kenney et al., “Downregulation of proinflammatory cytokine release in whole blood from septic patients,” Blood, vol. 85, no. 5, pp. 1341–1347, 1995. View at Google Scholar · View at Scopus
  45. A. Wafaisade, R. Lefering, B. Bouillon et al., “Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery,” Critical Care Medicine, vol. 39, no. 4, pp. 621–628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Wutzler, T. Lustenberger, B. Relja, M. Lehnert, and I. Marzi, “Pathophysiology of multiple trauma: intensive care medicine and timing of treatment,” Chirurg, vol. 84, no. 9, pp. 753–758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lacatus, “Innate immunity in surgical patients,” Chirurgia (Romania), vol. 108, no. 1, pp. 18–25, 2013. View at Google Scholar · View at Scopus
  48. E. López-Collazo and C. del Fresno, “Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences,” Critical Care, vol. 17, no. 6, article no. 242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Morris and L. Li, “Molecular mechanisms and pathological consequences of endotoxin tolerance and priming,” Archivum Immunologiae et Therapiae Experimentalis, vol. 60, no. 1, pp. 13–18, 2012. View at Publisher · View at Google Scholar
  50. B. Beutler, X. Du, and A. Poltorak, “Identification of toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies,” Journal of Endotoxin Research, vol. 7, no. 4, pp. 277–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Tsujimoto, S. Ono, T. Majima et al., “Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress,” Clinical Immunology, vol. 119, no. 2, pp. 180–187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. H. An, H. Xu, Y. Yu et al., “Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathways,” Immunology Letters, vol. 81, no. 3, pp. 165–169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. K. Biswas and E. Lopez-Collazo, “Endotoxin tolerance: new mechanisms, molecules and clinical significance,” Trends in Immunology, vol. 30, no. 10, pp. 475–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Kobayashi, L. D. Hernandez, J. E. Galán, C. A. Janeway Jr., R. Medzhitov, and R. A. Flavell, “IRAK-M is a negative regulator of Toll-like receptor signaling,” Cell, vol. 110, no. 2, pp. 191–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Escoll, C. Del Fresno, L. García et al., “Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients,” Biochemical and Biophysical Research Communications, vol. 311, no. 2, pp. 465–472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Ditschkowski, E. Kreuzfelder, V. Rebmann et al., “HLA-DR expression and soluble HLA-DR levels in septic patients after trauma,” Annals of Surgery, vol. 229, no. 2, pp. 246–254, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. C.-X. Hu, X. Xu, H.-P. Liang, F.-L. Lu, L.-Q. Shen, and T.-Z. Hao, “Changes in human leukocyte antigen-DR expression on monocytes and its value of prediction on infection complication in trauma patients,” Chinese Critical Care Medicine, vol. 16, no. 4, pp. 193–197, 2004. View at Google Scholar · View at Scopus
  58. A. Pachot, G. Monneret, A. Brion et al., “Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients,” Critical Care Medicine, vol. 33, no. 1, pp. 31–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Fumeaux and J. Pugin, “Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 11, pp. 1475–1482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Hietbrink, L. Koenderman, M. Althuizen, J. Pillay, V. Kamp, and L. P. H. Leenen, “Kinetics of the innate immune response after trauma: implications for the development of late onset sepsis,” Shock, vol. 40, no. 1, pp. 21–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Hoechst, L. A. Ormandy, M. Ballmaier et al., “A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells,” Gastroenterology, vol. 135, pp. 234–243, 2008. View at Google Scholar
  62. P. Filipazzi, R. Valenti, V. Huber et al., “Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine,” Journal of Clinical Oncology, vol. 25, no. 18, pp. 2546–2553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Albertsmeier, D. Quaiser, V. Von Dossow-Hanfstingl, H. Winter, E. Faist, and M. K. Angele, “Major surgical trauma differentially affects T-cells and APC,” Innate Immunity, vol. 21, no. 1, pp. 55–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Janols, C. Bergenfelz, R. Allaoui et al., “A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases,” Journal of Leukocyte Biology, vol. 96, no. 5, pp. 685–693, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. I. Grzelak, W. L. Olszewski, M. Zaleska et al., “Surgical trauma evokes a rise in the frequency of hematopoietic progenitor cells and cytokine levels in blood circulation,” European Surgical Research, vol. 30, no. 3, pp. 198–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. D. H. Livingston, D. Anjaria, J. Wu et al., “Bone marrow failure following severe injury in humans,” Annals of Surgery, vol. 238, no. 5, pp. 748–753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Heftrig, R. Sturm, I. Marzi, and B. Relja, “Impaired TLR4 expression on either stimulated or naive CD14+ monocytes may be responsible for their functional suppression after trauma,” in Proceedings of the 16th Meeting of the European Shock Society, Cologne, Germany, 2015.